Aspen Aerogels, Inc. (ASPN) stock plummeted 23.58% in after-hours trading on Wednesday following the release of its fourth-quarter 2024 financial results and disappointing first-quarter 2025 guidance.
While the company's Q4 revenue of $123.1 million beat consensus estimates of $120.8 million, and its Q4 EPS of $0.14 also topped expectations of $0.09, the market reacted negatively to its Q1 2025 guidance.
Aspen Aerogels provided a weak Q1 2025 revenue guidance range of $75 million to $95 million, significantly below the consensus estimate of $104.22 million. Additionally, the company's Q1 EPS guidance range of ($0.18) to $0.00 fell short of the consensus estimate of $0.08.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.